Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IN-207907 in Elderly Patients With Sarcopenia
NCT07668180Phase 2Not yet recruiting
- Sponsor
- HK inno.N Corporation
- Start
- Sep 2026
- Primary completion
- Feb 2028
01
Overview
A Phase 2 trial of IN-207907 in Sarcopenia, sponsored by HK inno.N Corporation. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
IN-207907
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on NCT07668180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07668180.